On April 10, 2015, GORYO Chemical Inc. announces that 300 million yen series B 3rd party allotment of new shares with UTEC.

By raising funds this time, Goryo will further expand fluorescent probe products in the life science business, promote clinical development using fluorescent probes as cancer diagnostic agents, and accelerate practical application at an early stage.

For details, please refer to the public article of the company HP.
http://goryochemical.com/english/